ADC Therapeutics (ADCT) Inventory (2021 - 2026)

ADC Therapeutics has disclosed Inventory across 6 years of filings, most recently posting $4.9 million for Q2 2026.

• In Q2 2026, Inventory fell 72.23% year-over-year to $4.9 million; the TTM figure through Jun 2026 stood at $4.9 million (down 72.23% YoY), while the FY2025 annual figure was $4.2 million, up 85.87% from the prior year.
• Inventory came in at $4.9 million for Q2 2026 at ADC Therapeutics, up from $4.8 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $22.7 million in Q3 2023 to a low of $2.3 million in Q4 2024.
• Average Inventory over 5 years is $13.8 million, with a median of $15.9 million recorded in 2022.
• Year-over-year, Inventory soared 96.62% in 2022 and plunged 86.09% in 2024.
• Over 5 years, Inventory stood at $12.1 million in 2022, then jumped by 33.99% to $16.2 million in 2023, then tumbled by 86.09% to $2.3 million in 2024, then jumped by 85.87% to $4.2 million in 2025, then advanced by 17.88% to $4.9 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $4.9 million in Q2 2026, $4.8 million in Q1 2026, and $4.2 million in Q4 2025.